Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Nektar Therapeutics (NASDAQ:NKTR) 8 0 0
PDL BioPharma Inc. (NASDAQ:PDLI) 13 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 19 0 1
VIVUS, Inc. (NASDAQ:VVUS) 21 0 0
Santarus, Inc. (NASDAQ:SNTS) 15 1 14

With the returns demonstrated by Insider Monkey’s tactics, everyday investors should always watch hedge fund and insider trading sentiment, and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Page 2 of 2